This is the list of Schedule III controlled substances as defined by the United States Controlled Substances Act at and 21 CFR 1308.13. The following findings are required for substances to be placed in this schedule:[1]
- The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II.
- The drug or other substance has a currently accepted medical use in treatment in the United States.
- Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The complete list of Schedule III substances is as follows. The Administrative Controlled Substances Code Number and Federal Register citation for each substance is included.
Stimulants
ACSCN | Drug |
---|---|
1405 | See 21 CFR 1308.13(b)(1) |
1228 | Benzphetamine[2] |
1645 | Chlorphentermine[2] |
1647 | Clortermine[2] |
1615 | Phendimetrazine[2] |
Depressants
ACSCN | Drug |
---|---|
2100 | Any derivative of barbituric acid[3][note 1] |
2510 | Chlorhexadol[3][note 1] |
2020 | Embutramide[4] |
2012 | FDA-approved oxybate products[5] |
2261 | Perampanel[6] |
7285 | Ketamine[7] |
7300 | Lysergic acid[3][note 1] |
7310 | Lysergic acid amide[3][note 1] |
2575 | Methyprylon[3][note 1] |
2600 | Sulfondiethylmethane[3][note 1] |
2605 | Sulfonethylmethane[3][note 1] |
2610 | Sulfonmethane[3][note 1] |
7295 | Tiletamine and zolazepam[8] |
Others
ACSCN | Drug |
---|---|
9400 | Nalorphine[3][note 1] |
Narcotics
ACSCN | Drug |
---|---|
9803 | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium[3][note 1] |
9804 | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts[3][note 1] |
9807 | Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts[3][note 1] |
9808 | Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts[3][note 1] |
9809 | Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts[3][note 1] |
9810 | Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts[3][note 1] |
9064 | Buprenorphine[9] |
Steroids
ACSCN | Drug |
---|---|
4000 | Anabolic steroids |
Hallucinogens
ACSCN | Drug |
---|---|
7369 | Dronabinol in sesame oil and encapsulated in a soft gelatin capsule[10] |
Notes
References
- ↑ retrieved September 3, 2014
- 1 2 3 4 Ingersoll, John (June 15, 1973). "Schedules of Controlled Substances; Placement of Benzphetamine, Chlorphentermine, Clotermine, Diethylpropion, Mazindol, Phendimetrazine, and Phentermine in Schedule III" (PDF). Isomer Design. Bureau of Narcotics and Dangerous Drugs. Archived (PDF) from the original on May 19, 2019. Retrieved January 16, 2023.
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Bartels Jr., John R. (June 20, 1974). "PART 1308— SCHEDULES OF CONTROLLED SUBSTANCES: Annual Publication" (PDF). Government Publishing Office. Drug Enforcement Administration. Archived from the original (PDF) on September 6, 2023. Retrieved September 6, 2023.
- ↑ Leonhart, Michele (August 29, 2006). "Schedules of Controlled Substances: Placement of Embutramide Into Schedule III". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
- ↑ Marshall, Donnie (March 13, 2000). "Schedules of Controlled Substances: Addition of Gamma-Hydroxybutyric Acid to Schedule I". Federal Register. Drug Enforcement Administration.
- ↑ Harrigan, Thomas (October 22, 2013). "Department of Justice. Drug Enforcement Administration. Schedules of Controlled Substances: Placement of Perampanel into Schedule III" (PDF). Federal Register. Office of the Federal Register, National Archives and Records Administration. 78 (204): 62500–62506. Retrieved 22 February 2014.
- ↑ Marshall, Donnie (July 13, 1999). "Schedules of Controlled Substances: Placement of Ketamine into Schedule III". Federal Register. Drug Enforcement Administration. Archived from the original on September 6, 2023. Retrieved September 6, 2023.
- ↑ Lawn, John (January 21, 1987). "Schedules of Controlled Substances: Placement of Preparations Which Contain Both Tiletamine and Zolazepam into Schedule III" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.
- ↑ Brown, John (October 7, 2002). "Schedules of Controlled Substances: Rescheduling of Buprenorphine From Schedule V to Schedule III". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
- ↑ Marshall, Donnie (July 2, 1999). "Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III" (PDF). Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.